BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2020
View the entire original 990 at ProPublica ↗
- Organization
- BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
- Tax period
- 2020-01-01 to 2020-12-31
- Filed
- 2021-11-13
- IRS object ID
- 202133179349301643
- Schema version
- 2020v4.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule L
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2021-11-13T13:36:51-06:00 | ReturnTs |
| Tax Period End | 2020-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 410746749 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CLIFTONLARSONALLEN LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 901 N GLEBE ROAD SUITE 200 | AddressLine1Txt |
| City | ARLINGTON | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22203 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2020-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 521224577 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BIOTECHNOLOGY INNOVATION ORGANIZATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | BIOT | BusinessNameControlTxt |
| Phone | 2029629200 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1201 MARYLAND AVE SW NO 900 | AddressLine1Txt |
| City | WASHINGTON | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20024 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | STEPHEN JASKO | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 2029629200 | PhoneNum |
| Signature | 2021-11-12 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | STEPHEN | PersonFirstNm |
| Person Last | JASKO | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | XXX-XX-XXXX | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | AMY CHAPMAN | PreparerPersonNm |
| PTIN | P00843460 | PTIN |
| Phone | 5712279500 | PhoneNum |
| Preparation | 2021-11-12 | PreparationDt |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 3 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2020 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | MICHELLE MCMURRY-HEATH | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1201 MARYLAND AVE SW NO 900 | AddressLine1Txt |
| City | WASHINGTON | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20024 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $102,100,535 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c | Yes (X) | Organization501cInd |
| Website Address | WWW.BIO.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1993 | FormationYr |
| Legal Domicile State | DC | LegalDomicileStateCd |
| Activity Or Mission | SUPPORT THE BIOTECHNOLOGY INDUSTRY AND TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND. | ActivityOrMissionDesc |
| Voting Members Governing Body | 106 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 106 | VotingMembersIndependentCnt |
| Total Employee | 214 | TotalEmployeeCnt |
| Total Volunteers | 123 | TotalVolunteersCnt |
| Total Gross UBI | $788,005 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $43,972 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $0 | PYContributionsGrantsAmt |
| CY Contributions Grants | $0 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $75,437,314 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $41,958,016 | CYProgramServiceRevenueAmt |
| PY Investment Income | $3,168,579 | PYInvestmentIncomeAmt |
| CY Investment Income | $6,102,556 | CYInvestmentIncomeAmt |
| PY Other Revenue | $13,831,376 | PYOtherRevenueAmt |
| CY Other Revenue | $29,218,945 | CYOtherRevenueAmt |
| PY Total Revenue | $92,437,269 | PYTotalRevenueAmt |
| CY Total Revenue | $77,279,517 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $3,162,700 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $2,976,500 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $39,303,857 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $40,492,059 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $53,724,995 | PYOtherExpensesAmt |
| CY Other Expenses | $38,376,099 | CYOtherExpensesAmt |
| PY Total Expenses | $96,191,552 | PYTotalExpensesAmt |
| CY Total Expenses | $81,844,658 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$3,754,283 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$4,565,141 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $84,368,104 | TotalAssetsBOYAmt |
| Total Assets EOY | $76,544,473 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $36,733,362 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $32,801,999 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $47,634,742 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $43,742,474 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Desc | ADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2020 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT BIOETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2020 ADVOCACY ACCOMPLISHMENTS: - PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.THE EMERGING COMPANIES SECTION 2020 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES IN THE TAX REFORM DEBATE.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.THE FOOD & AGRICULTURE SECTION 2020 ADVOCACY ACCOMPLISHMENTS: - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS FOR AG-BIOTECH PRODUCTS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - ADVOCATED IN LEGISLATURES AND COURTS TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2020 ADVOCACY ACCOMPLISHMENTS: - SUPPORTED A RENEWABLE CHEMICALS REPORT.- ADVOCATED FOR EPA TO TREAT ALL SUSTAINABLY SOURCED BIOMASS AS ELIGIBLE MEASURES FOR EMISSIONS REDUCTION CREDIT (ERC) GENERATION. - ADVOCATED REGARDING THE IMPLEMENTATION OF THE TOXIC SUBSTANCES CONTROL ACT (TSCA) AS AMENDED BY CONGRESS, AS WELL AS ISSUES RELATING TO THE NATIONAL BIOENGINEERED FOOD DISCLOSURE ACT.- ENGAGED WITH THE ADMINISTRATION'S REVIEW OF THE COORDINATED FRAMEWORK FOR BIOTECHNOLOGY, INCLUDING WITH RESPECT TO THE REGULATION OF GENETICALLY ENGINEERED (GE) ALGAE. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | SERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES.THE BIO INTERNATIONAL CONVENTION ATTRACTS THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 76 COUNTRIES AND 48 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS AND OFFERS PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES.THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM AT THE CONVENTION HOSTS TENS OF THOUSANDS OF PARTNERING MEETINGS AMONG A FEW THOUSAND COMPANIES, ALONG WITH A COUPLE HUNDRED COMPANY PRESENTATIONS. THE CONVENTION HOSTS HUNDREDS OF SPEAKERS, AND OVER A THOUSAND EXHIBITIONS WITH INTERNATIONAL, REGIONAL AND STATE PAVILIONS (AND A NUMBER OF PRODUCT FOCUS ZONES).BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Described In Section501c3 | 0 | DescribedInSection501c3Ind |
| Schedule B Required | 0 | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Subject To Proxy Tax | Yes (1) | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | Yes (1) | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 143 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Employee | 214 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (1) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (1) | Form990TFiledInd |
| Foreign Financial Account | Yes (1) | ForeignFinancialAccountInd |
| Foreign Country | IN | ForeignCountryCd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (1) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 106 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 106 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (1) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | 0 | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | STEPHEN JASKO | PersonNm |
| Phone | 2029629200 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1201 MARYLAND AVENUE SW SUITE 990 | AddressLine1Txt |
| City | WASHINGTON | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20024 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (134 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| BRADFORD ZAKES | ||||||||
| TREASURER | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| STEVE ALBERS | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| BONNIE ANDERSON | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| STUART ARBUCKLE | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MARTIN BABLER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| DUANE BARNES | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| LAURA BEREZIN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| DOUG BERVEN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JEAN-JACQUES BIENAIME | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| CHRISTOPHER BOERNER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| CHRISTOPHE BOURDON | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| CARRIE BOURDOW | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| BRIAN BRAZEAU | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| IVAN CHEUNG | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MEENU CHHABRA | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JEFFREY CLELAND | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| RON COHEN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| BRUCE COZADD | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JOHN CROWLEY | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ROGER CRYSTAL | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| BASSIL DAHIYAT | ||||||||
| DIRECTOR (UNTIL 2/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| DOUGLAS DOERFLER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MARK DROZDOWSKI | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ERIC DUBE | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MARK ENYEDY | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| BARRY FLANNELLY | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ALEXANDRIA FORBES | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| CEDRIC FRANCOIS | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JULIE GERBERDING | ||||||||
| SECRETARY | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| KEVIN GORMAN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JUSTIN GOVER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| PATRICK GRUBER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| CHIRFI GUINDO | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SHEILA GUJRATHI | ||||||||
| DIRECTOR (UNTIL 12/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SEBASTIAN GUTH | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ALEXANDER HARDY | ||||||||
| DIRECTOR (UNTIL 12/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| STEVEN HARR | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| PAUL HASTINGS | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| RACHEL HAURWITZ | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| CHRISTOPHER HEALEY | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| RUSSELL HERNDON | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JENNIFER HOLMGREN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SCOTT HOLMSTROM | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ALEX KARNAL | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| DAVID KETTNER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JEFF KINDLER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| RACHEL KING | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SCOTT KOENIG | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SAMARTH KULKARNI | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JOSEPH LAROSA | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JOHN LEPORE | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| NICK LESCHLY | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JEREMY LEVIN | ||||||||
| CHAIR | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| LIZ LEWIS | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| TED LOVE | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SANDY MACRAE | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| GAIL MADERIS | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| PAIGE MAHANEY | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| AMEET MALLIK | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JOHN MARAGANORE | ||||||||
| IMMEDIATE PAST CHAIR | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| JEFFREY MARRAZZO | ||||||||
| DIRECTOR (UNTIL 2/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SHARON MATES | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JOHN MELO | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| PHILIP MILLER | ||||||||
| IMMEDIATE PAST CHAIR (UNTIL 10/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| KENNETH MOCH | ||||||||
| DIRECTOR (UNTIL 7/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| BOB MORE | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MICHAEL MORRISSEY | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MICHAEL NARACHI | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| AMIR NASHAT | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| WILLIAM NEWELL | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| DAVID NICHOLSON | ||||||||
| DIRECTOR (UNTIL 9/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JULIA OWENS | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JOHN OYLER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| RICHARD PAULSON | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ADELENE PERKINS | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MARK PLATT | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| RICHARD POPS | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SHAJI PROCIDA | ||||||||
| DIRECTOR (UNTIL 1/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MARK PRUZANSKI | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SOFIE QIAO | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MICHAEL RAAB | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ANNA RATH | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ELENA RICE | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| HOWARD ROBIN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MICHAEL RUGGIERO | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MICHAEL RYAN | ||||||||
| DIRECTOR (UNTIL 2/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| AMBER SALZMAN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JAMES SAPIRSTEIN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| GEORGE SCANGOS | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| CHRISTOPHE SCHILLING | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| DIANE SHANAHAN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| CHRISTI SHAW | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| BILL SIBOLD | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| NANCY SIMONIAN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| DUANE SIMPSON | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ERIKA SMITH | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ELAINE SORG | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| CHRIS STANDLEE | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| EDDIE SULLIVAN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JENNIFER TAUBERT | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| KARSTEN TEMME | ||||||||
| DIRECTOR (UNTIL 1/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| BRIAN THOME | ||||||||
| DIRECTOR (UNTIL 9/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MARK TIMNEY | ||||||||
| DIRECTOR (UNTIL 1/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| HELEN TORLEY | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| MARK TRUDEAU | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| RICK TURNER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| GIL VAN BOKKELEN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| CHARL VAN ZYL | ||||||||
| DIRECTOR (UNTIL 2/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| TIMOTHY WALBERT | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| OLIVER WALKER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ROBERT WALSH | ||||||||
| DIRECTOR (UNTIL 1/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| HENRIK WAREBORN | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SUE WASHER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| HUGH WELSH | ||||||||
| IMMEDIATE PAST CHAIR (UNTIL 4/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ANNE WHITE | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| THOMAS WIGGANS | ||||||||
| DIRECTOR (UNTIL 4/20) | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ROBERT WILLS | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| RICK WINNINGHAM | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| SYLVIA WULF | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| ROGER WYSE | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JOHN YOUNG | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| BERNHARDT ZEIHER | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JILL ZULLO | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JAMES GREENWOOD | ||||||||
| PRESIDENT AND CEO (UNTIL 5/31/20) | 40.00 | Yes (X) | $7,568,068 | $0 | $16,043 | |||
| MICHELLE MCMURRY-HEATH | ||||||||
| PRESIDENT AND CEO | 40.00 | Yes (X) | $1,198,049 | $0 | $42,546 | |||
| YVETTE WHITE-WIGGINS | ||||||||
| SVP & CFO (UNTIL 8/4/20) | 40.00 | Yes (X) | $565,311 | $0 | $26,932 | |||
| STEPHEN JASKO | ||||||||
| CHIEF FINANCIAL OFFICER | 40.00 | Yes (X) | $203,253 | $0 | $2,664 | |||
| TOM DILENGE | ||||||||
| PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY DIV | 40.00 | $797,500 | $0 | $42,704 | Yes (X) | |||
| JOANNE DUNCAN | ||||||||
| PRESIDENT, MEMBERSHIP & BU | 40.00 | $752,077 | $0 | $38,602 | Yes (X) | |||
| DAN DURHAM | ||||||||
| EVP, HEALTH POLICY | 40.00 | $619,754 | $0 | $45,679 | Yes (X) | |||
| JEANNE HAGGERTY | ||||||||
| EVP, ADVOCACY | 40.00 | $544,327 | $0 | $19,814 | Yes (X) | |||
| RICH MASTERS | ||||||||
| EVP, PUBLIC AFFAIRS | 40.00 | $543,469 | $0 | $52,586 | Yes (X) | |||
| ELIZABETH ESHAM | ||||||||
| EVP, ECS & VP, SCIENCE & REGULATORY | 40.00 | $514,083 | $0 | $25,015 | Yes (X) | |||
| JOSEPH DAMOND | ||||||||
| EVP, INTERNATIONAL AFFAIRS | 40.00 | $512,148 | $0 | $48,479 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $13,818,039 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $361,064 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 98 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| DANIEL J EDELMAN INC | |||||
| 200 E RANDOLPH DRIVE SUITE 6300 | CHICAGO | IL | 60601 | CONSULTING SERVICES | $881,000 |
| NEW YORK MARRIOTT MARQUIS | |||||
| PO BOX 403003 | ATLANTA | GA | 30384 | CONVENTION & CONFERENCES CONTRACTOR | $777,971 |
| FREEMAN EXPOSITIONS | |||||
| PO BOX 660613 | DALLAS | TX | 75266 | CONVENTION & CONFERENCES CONTRACTOR | $692,141 |
| RUSSELL REYNOLDS ASN | |||||
| CHURCH ST PO BOX 6427 | NEW YORK | NY | 10249 | CONSULTING SERVICES | $616,584 |
| INOVA SOFTWARE INC | |||||
| 132 NASSAU ST SUITE 711 | NEW YORK | NY | 10038 | SERVICE PROVIDER | $549,550 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 73 | CntrctRcvdGreaterThan100KCnt |
Program Service Revenue ProgramServiceRevenueGrp (5 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt |
|---|---|---|---|---|
| MEMBERSHIP DUES | 900099 | $30,537,559 | $30,537,559 | |
| CONFERENCE/MEETING REVENUE | 541800 | $9,488,059 | $9,288,292 | $199,767 |
| EPF MEMBER SUPPORT | 900099 | $1,805,313 | $1,805,313 | |
| LEGAL & POLICY SUPPORT | 900099 | $106,823 | $106,823 | |
| ONLINE EDUCATION REVENUE | 900099 | $20,262 | $20,262 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $41,958,016 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,046,598 | TotalRevenueColumnAmt |
| Exclusion | $2,046,598 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $14,736,887 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $588,238 | UnrelatedBusinessRevenueAmt |
| Exclusion | $14,148,649 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $28,876,976 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $24,821,018 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $4,055,958 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $4,055,958 | TotalRevenueColumnAmt |
| Exclusion | $4,055,958 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | INSURANCE CLAIMS REVENUE | Desc |
| Business | 524298 | BusinessCd |
| Total Revenue Column | $14,480,000 | TotalRevenueColumnAmt |
| Exclusion | $14,480,000 | ExclusionAmt |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,058 | TotalRevenueColumnAmt |
| Exclusion | $2,058 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $14,482,058 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $77,279,517 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $41,758,249 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $788,005 | UnrelatedBusinessRevenueAmt |
| Exclusion | $34,733,263 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,976,500 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,023,219 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $28,923,355 | TotalAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $383,452 | TotalAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,698,161 | TotalAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,463,872 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $276,017 | TotalAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $76,151 | TotalAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,882,021 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $53,738 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,306,389 | TotalAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $370,766 | TotalAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $451,380 | TotalAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,364,139 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,987,239 | TotalAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $286,234 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,310,817 | TotalAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,348 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,027,054 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $634,933 | TotalAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $136,576 | TotalAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt |
|---|---|
| DUES & SUBSCRIPTIONS | $1,400,466 |
| TAXES PAID | $1,303,471 |
| OUTREACH | $366,412 |
| BAD DEBT EXPENSE | $102,611 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $33,337 | TotalAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $81,844,658 | TotalAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,112,278 | BOYAmt |
| EOY | $15,487,112 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,164,890 | BOYAmt |
| EOY | $967,224 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,901,799 | BOYAmt |
| EOY | $4,288,721 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,684,754 | BOYAmt |
| EOY | $2,624,031 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $8,350,364 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $7,573,630 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,324,871 | BOYAmt |
| EOY | $776,734 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $71,179,512 | BOYAmt |
| EOY | $52,400,651 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $84,368,104 | BOYAmt |
| EOY | $76,544,473 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,918,891 | BOYAmt |
| EOY | $18,997,300 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,579,354 | BOYAmt |
| EOY | $12,264,522 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,235,117 | BOYAmt |
| EOY | $1,540,177 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $36,733,362 | BOYAmt |
| EOY | $32,801,999 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $47,634,742 | BOYAmt |
| EOY | $43,742,474 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $47,634,742 | BOYAmt |
| EOY | $43,742,474 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $84,368,104 | BOYAmt |
| EOY | $76,544,473 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | -$4,565,141 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $650,373 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $22,500 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantially All Dues Nonded | 0 | SubstantiallyAllDuesNondedInd |
| Only In House Lobbying | 0 | OnlyInHouseLobbyingInd |
| Agree Carryover Prior Year | Yes (1) | AgreeCarryoverPriorYearInd |
| Dues Assessments | $30,537,559 | DuesAssessmentsAmt |
| Non Deductible Lbbyng Pltcl CY | $12,560,000 | NonDeductibleLbbyngPltclCYAmt |
| Non Ded Lbbyng Pltcl Cyov | $266,341 | NonDedLbbyngPltclCyovAmt |
| Non Deductible Lbbyng Pltcl Tot | $12,826,341 | NonDeductibleLbbyngPltclTotAmt |
| Aggregate Reported Dues Ntc | $12,520,399 | AggregateReportedDuesNtcAmt |
| Carried Over | $305,942 | CarriedOverAmt |
Schedule D IRS990ScheduleD
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $6,345,147 | OtherCostOrOtherBasisAmt |
| Depreciation | $6,110,120 | DepreciationAmt |
| Book Value | $235,027 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $276,745 | OtherCostOrOtherBasisAmt |
| Depreciation | $250,733 | DepreciationAmt |
| Book Value | $26,012 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $1,728,472 | OtherCostOrOtherBasisAmt |
| Depreciation | $1,212,777 | DepreciationAmt |
| Book Value | $515,695 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $776,734 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)
| DescDesc | AmtAmt |
|---|---|
| CAPITAL LEASE OBLIGATION | $29,713 |
| DEFERRED RENT | $1,250,043 |
| BIO-PAC | $260,421 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $1,540,177 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $79,054,943 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $650,373 | NetUnrealizedGainsInvstAmt |
| Other Revenue | $1,178,791 | OtherRevenueAmt |
| Revenue Not Reported | $1,829,164 | RevenueNotReportedAmt |
| Revenue Subtotal | $77,225,779 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $53,738 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $53,738 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $77,279,517 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $82,947,211 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $1,156,291 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $1,156,291 | ExpensesNotReportedAmt |
| Expenses Subtotal | $81,790,920 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $53,738 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $53,738 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $81,844,658 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART X, LINE 2: | THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(6) OF THE INTERNAL REVENUE CODE (IRC) AS A SECTION 501(A) ORGANIZATION. HOWEVER, THE ORGANIZATION IS SUBJECT TO FEDERAL AND DISTRICT OF COLUMBIA TAXES ON ITS UNRELATED BUSINESS INCOME. THE ORGANIZATION'S TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL, STATE, AND LOCAL AUTHORITIES. |
| PART XI, LINE 2D - OTHER ADJUSTMENTS: | FGR SPECIAL INITIATIVES REVENUE 170,540. CBI LOBBYING FUND 1,008,251. |
| PART XI, LINE 4B - OTHER ADJUSTMENTS: | BIONEWS ADVERTISING |
| PART XII, LINE 2D - OTHER ADJUSTMENTS: | FGR SPECIAL INITIATIVE EXPENSES 170,540. FOOD & AG SGR FUND 985,751. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, | 0 | 0 | PROGRAM SERVICES | CONFERENCES, ADVOCACY | $79,828 |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | PROGRAM SERVICES | CONFERENCES, ADVOCACY AND EDUCATION | $105,737 |
| SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, | 0 | 0 | PROGRAM SERVICES | ADVOCACY | $1,069 |
| SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, | 0 | 0 | PROGRAM SERVICES | ADVOCACY | $6,052 |
| SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO, | 0 | 0 | PROGRAM SERVICES | ADVOCACY | $15,997 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $208,683 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $208,683 | TotalSpentAmt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2: | THE ORGANIZATION HAS SUPPORTING DOCUMENTATION FOR THE AMOUNT THAT IS INVOICED FROM THE COMPANIES. |
| PART III ACCOUNTING METHOD: |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (75 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|
| CAPITAL AREA FOOD BANK INC | |||||||||
| 4900 PUERTO RICO AVE NE | WASHINGTON | DC | 20017 | 521167581 | 501(C)(3) | $10,000 | $0 | SUPPORT | |
| THE GLOBAL WOMEN'S INNOVATION NETWORK | |||||||||
| 233 PENNSYLVANIA AVENUE 2ND FLOOR | WASHINGTON | DC | 20003 | 271428117 | 501(C)(3) | $25,000 | $0 | SUPPORT | |
| US CHAMBER OF COMMERCE | |||||||||
| 1615 H STREET NW PO BOX 1200 | WASHINGTON | DC | 20062 | 530045720 | 501(C)(6) | $100,000 | $0 | SUPPORT | |
| NUS AMERICAN FOUNDATION INC | |||||||||
| 440 NORTH WOLFE ROAD | SUNNYVALE | CA | 94085 | 202368621 | 501(C)(3) | $16,000 | $0 | DONATION | |
| HEALTHCARE READY | |||||||||
| 1325 G ST NW SUITE 500 | WASHINGTON | DC | 20005 | 463134601 | 501(C)(3) | $45,000 | $0 | SUPPORT | |
| NATIONAL HEALTH COUNCIL | |||||||||
| 1730 M STREET NW SUITE 500 | WASHINGTON | DC | 20036 | 131624107 | 501(C)(3) | $25,000 | $0 | SPONSORSHIP | |
| EVERYLIFE FOUNDATION FOR RARE DISEASES | |||||||||
| 1012 14TH ST NW SUITE 500 | WASHINGTON | DC | 20005 | 264614274 | 501(C)(3) | $30,000 | $0 | CONTRIBUTION | |
| WASHINGTON LEGAL FOUNDATION | |||||||||
| 2009 MASSACHUSETTS AVE NW | WASHINGTON | DC | 20036 | 521071570 | 501(C)(3) | $10,000 | $0 | CONTRIBUTION | |
| WASHINGTON LEGAL FOUNDATION | |||||||||
| 2009 MASSACHUSETTS AVE NW | WASHINGTON | DC | 20036 | 521071570 | 501(C)(3) | $15,000 | $0 | SUPPORT | |
| CENTER FORWARD | |||||||||
| 555 12TH STREET NW SUITE 700 | WASHINGTON | DC | 20004 | 272429741 | 501(C)(4) | $35,000 | $0 | CONTRIBUTION | |
| THE CONGRESSIONAL INSTITUTE INC | |||||||||
| 1700 DIAGONAL RD SUITE 300 | ALEXANDRIA | VA | 22314 | 521504189 | 501(C)(4) | $15,000 | $0 | SUPPORT | |
| INFORMATION TECHNOLOGY AND INNOVATION FOUNDATION | |||||||||
| 1101 K ST NW SUITE 610 | WASHINGTON | DC | 20005 | 204403497 | 501(C)(3) | $30,000 | $0 | SUPPORT | |
| AMERICAN BRIDGE 21ST CENTURY FOUNDATION | |||||||||
| 770 P STREET NW APT 619 | WASHINGTON | DC | 20001 | 275278038 | 501(C)(4) | $250,000 | $0 | SUPPORT | |
| REPUBLICAN GOVERNORS ASSOCIATION | |||||||||
| 1747 PENNSYLVANIA AVE NW SUITE 250 | WASHINGTON | DC | 20006 | 113655877 | 501(C)(4) | $100,000 | $0 | SUPPORT | |
| DEMOCRATIC GOVERNORS ASSOCIATION | |||||||||
| 1401 K ST NW SUITE 200 | WASHINGTON | DC | 20005 | 521304889 | 527 | $100,000 | $0 | SPONSORSHIP | |
| OREGON BIOSCIENCE ASSOCIATION | |||||||||
| 2828 SW CORBETT AVE SUITE 115 | PORTLAND | OR | 97201 | 931009329 | 501(C)(6) | $30,000 | $0 | SPONSORSHIP | |
| MAJORITY FORWARD | |||||||||
| 700 13TH ST NW SUITE 600 | WASHINGTON | DC | 20005 | 474368320 | 501(C)(4) | $500,000 | $0 | SUPPORT | |
| ONE NATION | |||||||||
| 45 N HILL DRIVE SUITE 100 | WARRENTON | VA | 20186 | 271937961 | 501(C)(4) | $250,000 | $0 | CONTRIBUTION | |
| NATIONAL HEALTH COUNCIL | |||||||||
| 1730 M STREET NW SUITE 500 | WASHINGTON | DC | 20036 | 131624107 | 501(C)(3) | $10,000 | $0 | SPONSORSHIP | |
| ALLIANCE TO PROTECT MEDICAL INNOVATION | |||||||||
| 1220 L ST NW SUITE 100 488 | WASHINGTON | DC | 20005 | 831354631 | 501(C)(4) | $145,000 | $0 | CONTRIBUTION | |
| BIONJ INC | |||||||||
| 1255 WHITEHORSE-MERCERVILLE RD | TRENTON | NJ | 08619 | 223284393 | 501(C)(6) | $15,000 | $0 | SPONSORSHIP | BUILDING B - SUITE 514 |
| MASSACHUSETTS BIOTECHNOLOGY COUNCIL | |||||||||
| 300 TECHNOLOGY SQUARE 8TH FLOOR | CAMBRIDGE | MA | 02139 | 222693047 | 501(C)(6) | $6,000 | $0 | SPONSORSHIP | |
| IOWA BIOTECH ASSOCIATION | |||||||||
| 900 E DES MOINES ST | DES MOINES | IA | 50309 | 391885797 | 501(C)(6) | $7,500 | $0 | SUPPORT | |
| NORTH CAROLINA BIOSCIENCE ORGANIZATION | |||||||||
| PO BOX 14354 | RESEARCH TRIANGLE PARK | NC | 27709 | 561880780 | 501(C)(6) | $6,000 | $0 | SPONSORSHIP | |
| BIOOHIO | |||||||||
| 1275 KINNEAR RD | COLUMBUS | OH | 43212 | 341577705 | 501(C)(3) | $12,000 | $0 | SPONSORSHIP | |
| LIFE SCIENCE WASHINGTON | |||||||||
| 1551 EASTLAKE AVE E SUITE 300 | SEATTLE | WA | 98102 | 911453398 | 501(C)(6) | $11,500 | $0 | SPONSORSHIP | |
| MARYLAND TECHNOLOGY COUNCIL INC | |||||||||
| 9841 WASHINGTONIAN BLVD SUITE 200 | GAITHERSBURG | MD | 20878 | 204950778 | 501(C)(6) | $15,000 | $0 | SUPPORT | |
| LIFE SCIENCE TENNESSEE | |||||||||
| 217 5TH AVE NORTH SUITE 200 | NASHVILLE | TN | 37219 | 621776913 | 501(C)(6) | $7,500 | $0 | SPONSORSHIP | |
| ARIZONA BIOINDUSTRY ASSOCIATION | |||||||||
| 107 S SOUTHGATE DRIVE | CHANDLER | AZ | 85226 | 860938465 | 501(C)(6) | $15,000 | $0 | SPONSORSHIP | |
| LIFE SCIENCE PENNSYLVANIA | |||||||||
| 650 EAST SWEDESFORD RD SUITE 190 | WAYNE | PA | 19087 | 251621500 | 501(C)(6) | $10,000 | $0 | SPONSORSHIP | |
| MASSACHUSETTS BIOTECHNOLOGY COUNCIL | |||||||||
| 300 TECHNOLOGY SQUARE 8TH FLOOR | CAMBRIDGE | MA | 02139 | 222693047 | 501(C)(6) | $10,000 | $0 | SPONSORSHIP | |
| VIRGINIA BIOTECHNOLOGY ASSOCIATION | |||||||||
| 800 E LEIGH ST SUITE 14 | RICHMOND | VA | 23219 | 541644709 | 501(C)(6) | $12,500 | $0 | SPONSORSHIP | |
| GEORGIA BIO | |||||||||
| 999 PEACHTREE AVE NE SUITE 1800 | ATLANTA | GA | 30309 | 581849665 | 501(C)(3) | $12,500 | $0 | SPONSORSHIP | |
| PERSONALIZED MEDICINE COALITION | |||||||||
| 1225 NEW YORK AVE SUITE 450 | WASHINGTON | DC | 20005 | 542134884 | 501(C)(3) | $10,000 | $0 | SUPPORT | |
| NATIONAL HEALTH COUNCIL | |||||||||
| 1730 M STREET NW SUITE 500 | WASHINGTON | DC | 20036 | 131624107 | 501(C)(3) | $25,000 | $0 | SPONSORSHIP | |
| NATIONAL PSORIASIS FOUNDATION | |||||||||
| 6600 SW 92ND AVE SUITE 300 | PORTLAND | OR | 97223 | 930571472 | 501(C)(3) | $15,000 | $0 | SUPPORT | |
| CANCER SUPPORT COMMUNITY | |||||||||
| 734 15TH STREET NW SUITE 300 | WASHINGTON | DC | 20005 | 954163931 | 501(C)(3) | $25,000 | $0 | SPONSORSHIP | |
| CYSTIC FIBROSIS FOUNDATION | |||||||||
| 4550 MONTGOMERY AVENUE SUITE 350N | BETHESDA | MD | 20814 | 131930701 | 501(C)(3) | $7,500 | $0 | SPONSORSHIP | |
| AMERICAN CANCER SOCIETY ACTION NETWORK INC | |||||||||
| 555 11TH STREET SUITE 300 | WASHINGTON | DC | 20004 | 522340031 | 501(C)(4) | $10,000 | $0 | SPONSORSHIP | |
| LUPUS FOUNDATION OF AMERICA INC | |||||||||
| 2121 K STREET NW SUITE 200 | WASHINGTON | DC | 20037 | 431131436 | 501(C)(3) | $10,000 | $0 | SUPPORT | |
| EPILEPSY FOUNDATION | |||||||||
| 8301 PROFESSIONAL PLACE EAST SUITE | LANDOVER | MD | 207852353 | 520856660 | 501(C)(3) | $15,000 | $0 | SUPPORT | 200 |
| NATIONAL HEALTH COUNCIL | |||||||||
| 1730 M STREET NW SUITE 500 | WASHINGTON | DC | 20036 | 131624107 | 501(C)(3) | $25,000 | $0 | SPONSORSHIP | |
| NATIONAL HEALTH COUNCIL | |||||||||
| 1730 M STREET NW SUITE 500 | WASHINGTON | DC | 20036 | 131624107 | 501(C)(3) | $25,000 | $0 | SPONSORSHIP | |
| AMERICAN CANCER SOCIETY ACTION NETWORK INC | |||||||||
| 555 11TH STREET SUITE 300 | WASHINGTON | DC | 20004 | 522340031 | 501(C)(4) | $15,000 | $0 | SUPPORT | |
| ARTHRITIS FOUNDATION | |||||||||
| 1355 PEACHTREE ST 600 | ATLANTA | GA | 30309 | 581341679 | 501(C)(3) | $20,000 | $0 | SPONSORSHIP | |
| HIV AND HEPATITIS POLICY INSTITUTE | |||||||||
| 1602B BELMONT ST NW | WASHINGTON | DC | 20009 | 844147678 | 501(C)(3) | $10,000 | $0 | SUPPORT | |
| EVERYLIFE FOUNDATION FOR RARE DISEASES | |||||||||
| 1012 14TH ST NW SUITE 500 | WASHINGTON | DC | 20005 | 264614274 | 501(C)(3) | $15,000 | $0 | SPONSORSHIP | |
| HEALTHY WOMEN | |||||||||
| 1 HARDING RD SUITE 102A | RED BANK | NJ | 07701 | 521624846 | 501(C)(3) | $10,000 | $0 | SPONSORSHIP | |
| RESEARCHAMERICA | |||||||||
| 241 18TH STREET SOUTH SUITE 501 | ARLINGTON | VA | 22202 | 521609875 | 501(C)(3) | $25,000 | $0 | SPONSORSHIP | |
| PREVENT CANCER FOUNDATION | |||||||||
| 1600 DUKE ST SUITE 500 | ALEXANDRIA | VA | 22314 | 521429544 | 501(C)(3) | $8,000 | $0 | SPONSORSHIP | |
| ALLIANCE FOR AGING RESEARCH | |||||||||
| 1700 K STREET NW SUITE 740 | WASHINGTON | DC | 20006 | 541379174 | 501(C)(3) | $15,000 | $0 | SPONSORSHIP | |
| FRIENDS OF CANCER RESEARCH | |||||||||
| 1800 M ST NW SUITE 1050 SOUTH TOWER | WASHINGTON | DC | 20036 | 521983273 | 501(C)(3) | $10,000 | $0 | SPONSORSHIP | TOWER |
| RI BIO | |||||||||
| PO BOX 5680 53 BROAD ST | PROVIDENCE | RI | 02903 | 462858053 | 501(C)(6) | $6,000 | $0 | SPONSORSHIP | |
| BIOUTAH | |||||||||
| PO BOX 58531 | SALT LAKE CITY | UT | 84158 | 900899204 | 501(C)(6) | $8,000 | $0 | SPONSORSHIP | |
| GEORGIA BIOMEDICAL PARTNERSHIP INC | |||||||||
| 999 PEACHTREE AVE NE SUITE 1800 | ATLANTA | GA | 30309 | 581849665 | 501(C)(3) | $22,500 | $0 | SUPPORT AND SPONSORSHIP | |
| LIFE SCIENCES PENNSYLVANIA | |||||||||
| 650 EAST SWEDESFORD RD SUITE 190 | WAYNE | PA | 19087 | 251621500 | 501(C)(6) | $11,500 | $0 | SPONSORSHIP | |
| MONTANA BIOSCIENCE ALLIANCE | |||||||||
| P O BOX 1773 | BILLINGS | MT | 59103 | 201647600 | 501(C)(6) | $20,000 | $0 | SUPPORT | |
| MARYLAND TECHNOLOGY COUNCIL INC | |||||||||
| 9841 WASHINGTONIAN BLVD SUITE 200 | GAITHERSBURG | MD | 20878 | 204950778 | 501(C)(6) | $10,000 | $0 | SUPPORT | |
| BIONJ | |||||||||
| 1255 WHITEHORSE-MERCERVILLE RD | TRENTON | NJ | 08619 | 223284393 | 501(C)(6) | $10,000 | $0 | SUPPORT | BUILDING B - SUITE 514 |
| TEXAS HEALTHCARE & BIOSCIENCE | |||||||||
| 815 BRAZOS ST SUITE 310 | AUSTIN | TX | 78701 | 760501034 | 501(C)(6) | $15,000 | $0 | SPONSORSHIP | |
| LEUKEMIA & LYMPHOMA SOCIETY | |||||||||
| 3601 EISENHOWER AVENUE SUITE 450 | ALEXANDRIA | VA | 22304 | 135644916 | 501(C)(3) | $10,000 | $0 | SPONSORSHIP | |
| NEHI | |||||||||
| 133 FEDERAL STREET 9TH FLOOR | BOSTON | MA | 02110 | 010624865 | 501(C)(3) | $7,000 | $0 | SPONSORSHIP | |
| BIONJ INC | |||||||||
| 1255 WHITEHORSE-MERCERVILLE RD | TRENTON | NJ | 08619 | 223284393 | 501(C)(6) | $32,500 | $0 | SPONSORSHIP | BUILDING B - SUITE 514 |
| NEW YORK BIOTECHNOLOGY ASSOCIATION | |||||||||
| 25 HEALTH SCIENCES DR SUITE 203 | STONY BROOK | NY | 11790 | 113026494 | 501(C)(6) | $15,000 | $0 | SPONSORSHIP | |
| AMERICAN CANCER SOCIETY ACTION NETWORK INC | |||||||||
| 555 11TH STREET SUITE 300 | WASHINGTON | DC | 20004 | 522340031 | 501(C)(4) | $10,000 | $0 | SPONSORSHIP | |
| THE COUNCIL OF STATE GOVERNMENTS LTD | |||||||||
| 1776 AVENUE OF THE STATES | LEXINGTON | KY | 40511 | 366000818 | 501(C)(3) | $25,000 | $0 | SUPPORT | |
| NCSL FOUNDATION FOR STATE LEGISLATURES | |||||||||
| 7700 EAST FIRST PLACE | DENVER | CO | 80230 | 742232576 | 501(C)(3) | $7,500 | $0 | SPONSORSHIP | |
| CLEAN FUELS WASHINGTON | |||||||||
| P O BOX 21961 | SEATTLE | WA | 98111 | 844490659 | 501(C)(6) | $15,000 | $0 | SUPPORT | |
| DEMOCRATIC GOVERNORS ASSOCIATION | |||||||||
| 1401 K ST NW SUITE 200 | WASHINGTON | DC | 20005 | 521304889 | 527 | $25,000 | $0 | SPONSORSHIP | |
| SAFE COMMUNITIES COALITION | |||||||||
| 1140 US HWY 287 SUITE 400-199 | BROOMFIELD | CO | 80020 | 852649962 | 501(C)(3) | $10,000 | $0 | CONTRIBUTION | |
| WOMEN IN GOVERNMENT FOUNDATION INC | |||||||||
| 444 N CAPITOL ST NW SUITE 401 | WASHINGTON | DC | 20001 | 541527192 | 501(C)(3) | $10,000 | $0 | SUPPORT | |
| ONE NATION | |||||||||
| 45 N HILL DRIVE SUITE 100 | WARRENTON | VA | 20186 | 271937961 | 501(C)(4) | $250,000 | $0 | CONTRIBUTION | |
| HAWAII FARM BUREAU FEDERATION | |||||||||
| PO BOX 253 | KUNIA | HI | 96759 | 990073460 | 501(C)(5) | $22,500 | $0 | SUPPORT | |
| CALIFORNIA LIFE SCIENCES ASSOCIATION | |||||||||
| 9191 TOWNE CENTRE DRIVE SUITE 450 | SAN DIEGO | CA | 92122 | 473226523 | 501(C)(6) | $250,000 | $0 | SUPPORT | |
| UNIVERSITY OF MARYLAND EASTERN SHORE | |||||||||
| 3002 HAZEL HALL | PRINCESS ANNE | MD | 21853 | 526002033 | 501(C)(1) | $7,000 | $0 | SPONSORSHIP | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 30 | Total501c3OrgCnt |
| Total Other Org | 31 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | BIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| First Class Or Charter Travel | Yes (X) | FirstClassOrCharterTravelInd |
| Travel For Companions | Yes (X) | TravelForCompanionsInd |
| Club Dues Or Fees | Yes (X) | ClubDuesOrFeesInd |
| Written Policy Ref T And E Expnss | 0 | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (1) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (1) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (1) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JAMES GREENWOOD | ||||||||||||||
| PRESIDENT AND CEO (UNTIL 5/31/20) | $682,418 | $0 | $944,886 | $0 | $5,940,764 | $0 | $8,550 | $0 | $7,493 | $0 | $7,584,111 | $0 | $0 | $0 |
| MICHELLE MCMURRY-HEATH | ||||||||||||||
| PRESIDENT AND CEO | $700,000 | $0 | $498,049 | $0 | $0 | $0 | $0 | $0 | $42,546 | $0 | $1,240,595 | $0 | $0 | $0 |
| TOM DILENGE | ||||||||||||||
| PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC | $550,000 | $0 | $247,500 | $0 | $0 | $0 | $8,550 | $0 | $34,154 | $0 | $840,204 | $0 | $0 | $0 |
| JOANNE DUNCAN | ||||||||||||||
| PRESIDENT, MEMBERSHIP & BU | $508,807 | $0 | $243,270 | $0 | $0 | $0 | $8,550 | $0 | $30,052 | $0 | $790,679 | $0 | $0 | $0 |
| DAN DURHAM | ||||||||||||||
| EVP, HEALTH POLICY | $478,341 | $0 | $141,413 | $0 | $0 | $0 | $8,550 | $0 | $37,129 | $0 | $665,433 | $0 | $0 | $0 |
| RICH MASTERS | ||||||||||||||
| EVP, PUBLIC AFFAIRS | $471,975 | $0 | $71,494 | $0 | $0 | $0 | $8,550 | $0 | $44,036 | $0 | $596,055 | $0 | $0 | $0 |
| YVETTE WHITE-WIGGINS | ||||||||||||||
| SVP & CFO (UNTIL 8/4/20) | $428,901 | $0 | $136,410 | $0 | $0 | $0 | $4,428 | $0 | $22,504 | $0 | $592,243 | $0 | $0 | $0 |
| JEANNE HAGGERTY | ||||||||||||||
| EVP, ADVOCACY | $426,700 | $0 | $117,627 | $0 | $0 | $0 | $5,475 | $0 | $14,339 | $0 | $564,141 | $0 | $0 | $0 |
| JOSEPH DAMOND | ||||||||||||||
| EVP, INTERNATIONAL AFFAIRS | $396,626 | $0 | $115,522 | $0 | $0 | $0 | $8,550 | $0 | $39,929 | $0 | $560,627 | $0 | $0 | $0 |
| ELIZABETH ESHAM | ||||||||||||||
| EVP, ECS & VP, SCIENCE & REGULATORY | $400,000 | $0 | $114,083 | $0 | $0 | $0 | $8,550 | $0 | $16,465 | $0 | $539,098 | $0 | $0 | $0 |
| STEPHEN JASKO | ||||||||||||||
| CHIEF FINANCIAL OFFICER | $103,253 | $0 | $100,000 | $0 | $0 | $0 | $0 | $0 | $2,664 | $0 | $205,917 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 1A | INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: COMPANIONS EXPENSE $10,275 |
| PART I, LINE 1B | THE CHIEF EXECUTIVE OFFICER HAS A PREPAID SPENDING ACCOUNT AT A LOCAL RESTAURANT, USED EXCLUSIVELY FOR BUSINESS PURPOSES. |
| PART I, LINES 4A-B | JAMES GREENWOOD- 457B - $478,389 JAMES GREENWOOD - 457(F) - $3,714,485.90 JAMES GREENWOOD - SEPARATION PAYMENT - $1,637,802 YVETTE WHITE WIGGINS - SEPARATION PAYMENT - $417,283 |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (2 entries)
| Relationship DescriptionRelationshipDescriptionTxt | TransactionTransactionAmt | TransactionTransactionDesc | Sharing Of RevenuesSharingOfRevenuesInd |
|---|---|---|---|
| LAURA GREENWOOD | |||
| DAUGHTER OF CEO | $49,334 | PAID EMPLOYEE OF ORGANIZATION | 0 |
| LILY DOEFLER | |||
| DAUGHTER OF A BOARD MEMBER | $63,933 | PAID EMPLOYEE OF ORGANIZATION | 0 |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (9 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 1 | THE BOARD OF DIRECTORS SHALL DESIGNATE BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION; THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION. |
| FORM 990, PART VI, SECTION A, LINE 6 | THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER. |
| FORM 990, PART VI, SECTION A, LINE 7A | AT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH DIRECTOR ON ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE. |
| FORM 990, PART VI, SECTION B, LINE 15 | FOR 2020, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2020, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH THE RELEVANT PROVISION OF THE EXECUTIVE AGREEMENT. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE PRESIDENTS OF THE TWO DIVISIONS AT BIO LED THE PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. |
| FORM 990, PART IX, LINE 11G | EC EMERGING PRIORITIES 8,213,426. WORKPLAN OBJECTIVES 135,356. INTERNS 18,035. TEMPORARY HELP 126,107. ECONOMIC STUDIES 562,500. CONSULTANTS AND OTHER PROFESSIONAL FEES 3,782,765. BIO-PAC ADMINISTRATIVE 21,355. BUSINESS DEVELOPMENT EXEC PRESENTATION 23,843. PROGRAM INITIATIVES 34,396. RECRUITMENT 270,869. BUSINESS STRATEGIES 6,590. EDUCATION 103,647. RESEARCH/FOCUS GROUPS 7,500. |
| FORM 990, PART XI, LINE 9: | NET EXCLUSIVE BUSINESS SOLUTION 22,500. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Controlled OrganizationControlledOrganizationInd | Public Charity StatusPublicCharityStatusTxt |
|---|---|---|---|---|---|---|---|---|---|
| EXCELLENCE THROUGH STEWARDSHIP | |||||||||
| 1201 MARYLAND AVE SW SUITE 900 | WASHINGTON | DC | 20024 | 263021330 | TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE PROMISE, ACHIEVEMENTS | DC | 501(C)(4) | 0 | |
| BIOTECHNOLOGY INSTITUTE | |||||||||
| 1201 MARYLAND AVE SW SUITE 900 | WASHINGTON | DC | 20024 | 251716917 | TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE CHALLENGES OF BIOTECH. | DC | 501(C)(3) | 0 | LINE 7 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (1) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | 0 | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | Yes (1) | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | 0 | SharingOfFacilitiesInd |
| Paid Employees Sharing | 0 | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (1) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (4 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt |
|---|---|
| EXCELLENCE THROUGH STEWARDSHIP | |
| B | $54,996 |
| EXCELLENCE THROUGH STEWARDSHIP | |
| Q | $54,191 |
| THE BIOTECHNOLOGY INSTITUTE | |
| D | $240,465 |
| THE BIOTECHNOLOGY INSTITUTE | |
| B | $55,240 |